Torrent Pharmaceuticals completes amalgamation of J. B. Chemicals & Pharmaceuticals; allots 4.19 crore shares
On 17 July 2026 (record date), Torrent Pharmaceuticals allotted 4,19,22,416 fully paid-up equity shares to eligible shareholders of J. B. Chemicals & Pharmaceuticals Limited pursuant to a Scheme of Amalgamation. The allotment, intimated to NSE on 20 July 2026, represents the completion of the scheme's share-based consideration structure. This merger combines two significant players in the Indian pharmaceutical sector and is governed by the amalgamation scheme as approved by the NCLT and sanctioned under the Companies Act, 2013. The transaction reflects the consolidation trend in mid-cap pharma.
Why it mattersPost-allotment, practitioners must ensure shareholder certification, creditor claims closure, and compliance with NCLT direction on scheme surplus or adjustment mechanisms-precedent on large pharma consolidation under current M&A regulatory architecture.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]
Sources
- NSE Corporate Announcement Archives · official
- NSE Listed Companies Database · official
- BSE Listed Companies · official
- Ministry of Corporate Affairs (MCA) - NCLT Orders Database · official
- BSE corporate announcements · official
- NSE corporate announcements · official
- CCI combination orders · official
Related deals
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers28 Oct 2026
- Fortis Healthcare Limited: Press Release28 Oct 2026 · ₹277 Cr
- Fortis Healthcare Limited: Acquisition28 Oct 2026
- ThinkLaw advises Jagsonpal Pharma on acquiring Group Pharma's wellness portfolio27 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026